Pan-cancer analysis for ADAM2 showed a high frequency of expression in breast (9.5%), lung (9.6%), bladder (16.7%), prostate (72.4%) and renal (74.7%) cancers (Fig. 6A and Supplementary Data 5). The gene discussed is ADAM2; the disease is cancer.